SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-17-000659
Filing Date
2017-12-21
Accepted
2017-12-21 14:57:05
Documents
1
Group Members
FOREST BASKETTM. JAMES BARRETTNEA 12 GP, LLCNEA PARTNERS 12, LIMITED PARTNERSHIPPATRICK J. KERINSPETER J. BARRISSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEA 12 LP / PROTEOSTASIS THERAPEUTICS - 13DA (#2) proteostasis-13da_18142.htm SC 13D/A 292782
  Complete submission text file 0001072613-17-000659.txt   294578
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
New Enterprise Associates 12, Limited Partnership (Filed by) CIK: 0001383391 (see all company filings)

IRS No.: 204670653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-89403 | Film No.: 171269176
SIC: 2834 Pharmaceutical Preparations